17931-56-5

Basic information

• Product Name: dimethyl bicyclo[2.2.1]hept-2-ene-2,3-dicarboxylate
• CAS NO: 17931-56-5
• Molecular Formula: C₁₁H₁₄O₄
• Molecular Weight: 210.2265
• Mol File: 17931-56-5.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 281.3°C at 760 mmHg
• Flash Point: 135.4°C
• Density: 1.238g/cm³
• Vapor Pressure: 0.00359mmHg at 25°C
• Refractive Index: 1.522
• CAS DataBase Reference: dimethyl bicyclo[2.2.1]hept-2-ene-2,3-dicarboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: dimethyl bicyclo[2.2.1]hept-2-ene-2,3-dicarboxylate(17931-56-5)
• EPA Substance Registry System: dimethyl bicyclo[2.2.1]hept-2-ene-2,3-dicarboxylate(17931-56-5)

Safety Data

• Hazardous Substances Data: 17931-56-5(Hazardous Substances Data)

Upstream product

• 947-57-9 dimethyl bicyclo[2.2.1]hept-2,5-diene-2,3-dicarboxylate 
• 762-42-5 dimethyl acetylenedicarboxylate 
• 542-92-7 cyclopenta-1,3-diene 

Downstream Products

• 1560642-78-5 C₂₇H₃₀ClN₅O₂ 
• 1560642-79-6 C₄₃H₅₀N₈O₄ 
• 1561214-03-6 C₃₃H₃₄N₈ 
• 1560649-16-2 C₄₇H₅₆N₁₀O₆ 
• 16508-04-6 bicyclo<2,2,1>hept-2-ene-2,3-dicarboxylic acid 
• 79008-33-6 (1S,2R,6S,7R)-5-(2,4,6-Trimethyl-phenyl)-3-oxa-4-aza-tricyclo[5.2.1.0^2,6]dec-4-ene-2,6-dicarboxylic acid dimethyl ester 
• 78999-03-8 (1S,2R,5R,6S,7R)-4-Methyl-5-phenyl-3-oxa-4-aza-tricyclo[5.2.1.0^2,6]decane-2,6-dicarboxylic acid dimethyl ester 
• 78999-12-9 (1S,2R,6S,7R)-5-Phenyl-3-oxa-4-aza-tricyclo[5.2.1.0^2,6]dec-4-ene-2,6-dicarboxylic acid dimethyl ester 

Relevant articles and documents

THRB RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD AND USE THEREOF

The present invention discloses a compound represented by the following Formula (I) and a pharmaceutically acceptable salt thereof. The compound improves the THRα selectivity while maintaining good THRβ agonistic activity, thereby improving properties of

BRIDGED RING COMPOUNDS AS HEPATITIS C VIRUS (HCV) INHIBITORS AND PHARMACEUTICAL APPLICATIONS THEREOF

Provided herein is a compound having Formula (I), or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, which can be used for treating HCV infection or a HCV disorder. Also provided herein are pharmaceutical compositions comprising the compounds disclosed herein, which can be used for treating HCV infection or a HCV disorder.

Regioselective Catalytic Transfer Hydrogenation of Dimethyl Bicyclohepta-2,5-diene-2,3-dicarboxylate, Dimethyl Bicyclohept-2-ene-2,3-dicarboxylate, and Related Compounds over Palladium on Carbon

The catalytic transfer hydrogenation (CTH) of dimethyl bicyclohepta-2,5-diene-2,3-dicarboxylate (3) on palladium on carbon is highly regioselective, giving predominant reduction at the least-substituted olefinic site.The CTH of dimethyl bicyclohept-2-ene-2,3-dicarboxylate also occurs with exclusive suprafacial exo addition of hydrogen to afford the endo isomer.An increase in the relative concentration of palladium on carbon (ca. 40-45 wt/wt percent based on the acceptor) accelerates the rate of CTH while the substituted cyclohexenes undergo CTH faster than cyclohexene with dimethyl bicyclohept-2-ene-2,3-dicarboxylate.